secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rafael Holdings, Inc. (RFL)
CIK:        0001713863
Form:       8-K
Filed at:   2023-06-13T23:59:59+00:00
Accession:  0001213900-23-048570
Event type: earnings
Sentiment:  positive
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rafael Holdings reports Q3 net loss of $1.5M; invests $2.1M in Cyclo Therapeutics
--------------------------------------------------------------------------------

- Net loss from continuing operations $1.5M ($0.06/sh) vs $5.0M ($0.25/sh) year ago.
- Cash, equivalents and marketable securities $82.4M as of April 30, 2023.
- Made initial $2.1M investment in Cyclo Therapeutics and agreement to invest additional $5M.
- R&D expenses fell to $0.7M from $1.4M on winding down early-stage programs.
- General and administrative expenses $2.3M for Q3, including $0.6M stock-based comp.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1713863/000121390023048570/0001213900-23-048570-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1713863/000121390023048570/ea180272-8k_rafaelhold.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-048570

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer